1.
Hiroshi Kawabata, Naohisa Tomosugi, Junya Kanda, Yasuhiro Tanaka, Kazuyuki Yoshizaki, Takashi Uchiyama. Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman’s disease. haematol [Internet]. 2007Jun.1 [cited 2024Apr.25];92(6):857-8. Available from: https://haematologica.org/article/view/4486